Cited by 887PI3K/AKT/mTOR signaling in cancerSignaling Pathways in DiseaseAutophagy in Disease and Therapy

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Open access

Sabers, Candace J., Martin, Mary M., Brunn, Gregory J., Williams, Josie M., Dumont, Francis J., Wiederrecht, Gregory, Abraham, Robert T.·1995·Journal of Biological Chemistry

DOI 10.1074/jbc.270.2.815

Open this paper in CoChat — free account Open PDF

Abstract

The immunosuppressive drug, rapamycin, interferes with an undefined signaling pathway required for the progression of G1-phase T-cells into S phase. Genetic analyses in yeast indicate that binding of rapamycin to its intracellular receptor, FKBP12, generates a toxic complex that inhibits cell growth in G1 phase. These analyses implicated two related proteins, TOR1 and TOR2, as targets of the FKBP12-rapamycin complex in yeast. In this study, we have used a glutathione S-transferase (GST)-FKBP12-rapamycin affinity matrix to isolate putative mammalian targets of rapamycin (mTOR) from tissue extracts. In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts. Binding experiments performed with rapamycin-sensitive and -resistant mutant clones derived from the YAC-1 T-lymphoma cell line demonstrate that the GST-FKBP12-rapamycin complex recovers significantly lower amounts of the candidate mTOR from rapamycin-resistant cell lines. The latter results suggest that mTOR is a relevant target of rapamycin in these cells. Finally, we report the isolation of a full-length mTOR cDNA that encodes a direct ligand for the FKBP12-rapamycin complex. The deduced amino acid sequence of mTOR displays 42 and 45% identity to those of yeast TOR1 and TOR2, respectively. These results strongly suggest that the FKBP12-rapamycin complex interacts with homologous ligands in yeast and mammalian cells and that the loss of mTOR function is directly related to the inhibitory effect of rapamycin on G1- to S-phase progression in T-lymphocytes and other sensitive cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.270.2.815

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,635
RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 1

Cafferkey, 1993, Mol. Cell. Biol., 13, 6012, 10.1128/MCB.13.10.6012 · DOI

Sorted by citations

Items 501–600 of 885

The evolution of the axonal transport toolkit
Surana, S., Villarroel‐Campos, D., Lazo, O. M., Moretto, E., Tosolini, A. P., Rhymes, E. R., Richter, S., Sleigh, J. N., & Schiavo, G. (2019) · Traffic · doi:10.1111/tra.12710 · Cited by 31
Gene disruption to evaluate the role of fungal candidate virulence genes
Kwon-Chung, K. J. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80053-2 · Cited by 30
Rapamycin Blocks IL-2-Driven T Cell Cycle Progression While Preserving T Cell Survival
Gonzalez, J., Harris, T., Childs, G. J., & Prystowsky, M. B. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0420 · Cited by 30
Recent advances in development of hetero-bivalent kinase inhibitors
Lee, S., Kim, J., Jo, J., Chang, J. W., Sim, J., & Yun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113318 · Cited by 30
USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling
Wang, D., Jin, X., Lei, M., Jiang, Y., Liu, Y., Yu, F., Guo, Y., Han, B., Yang, Y., Sun, W., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69134 · Cited by 28
Signals for Muscular Protein Turnover and Insulin Resistance in Critically Ill Patients: A Narrative Review
Chapela, S. P., Simancas‐Racines, D., Montalván, M., Frías-Toral, E., Simancas-Racines, A., Muscogiuri, G., Barrea, L., Sarno, G., Martinez, P. I., Reberendo, M. J., et al. (2023) · Nutrients · doi:10.3390/nu15051071 · Cited by 28
A Multi-Lineage Screen Reveals mTORC1 Inhibition Enhances Human Pluripotent Stem Cell Mesendoderm and Blood Progenitor Production
Nazareth, E. J. P., Rahman, N., Yin, T., & Zandstra, P. W. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.003 · Cited by 28
Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27–Stimulated Cytotoxicity of NK Cells
Zhou, W., Chang, K., Wu, K., Yang, H., Mei, J., Xie, F., Li, D., & Li, M. (2017) · Neoplasia · doi:10.1016/j.neo.2017.11.003 · Cited by 29
Translational geroscience: From invertebrate models to companion animal and human interventions
Lee, M. B., & Kaeberlein, M. R. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.002 · Cited by 28
Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications
Yang, L., Zhang, Z., Wang, D., Jiang, Y., & Liu, Y. (2022) · Current Drug Targets · doi:10.2174/1389450123666220111115528 · Cited by 27
Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implications
Danesi, R., Boni, J. P., & Ravaud, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.12.012 · Cited by 27
Targeting the Mammalian Target of Rapamycin in Lung Cancer
Vicary, G. W., & Roman, J. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.08.014 · Cited by 27
Targeting the mTOR pathway in breast cancer
Liu, J., Li, H., Zhou, F.-X., Yu, J.-W., Sun, L., & Han, Z.-H. (2017) · Tumor Biology · doi:10.1177/1010428317710825 · Cited by 27
Cross Talk Networks of Mammalian Target of Rapamycin Signaling With the Ubiquitin Proteasome System and Their Clinical Implications in Multiple Myeloma
Eichner, R., Fernández‐Sáiz, V., Targosz, B., & Bassermann, F. C. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.06.001 · Cited by 27
Rapamycin-induced autophagy activity promotes bone fracture healing in rats
Yang, G., Duan, X., Lin, D., LI, T., Luo, D., Wang, L., & Lian, K. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2660 · Cited by 27
FRAP DNA-Dependent Protein Kinase Mediates a Late Signal Transduced from Ultraviolet-Induced DNA Damage
Yarosh, D. B., Bizios, N., Kibitel, J. T., Goodtzova, K., Both, D., Goldfarb, S. B., Green, B., Brown, D., Cruz, P. D., & Dougherty, I. I. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00964.x · Cited by 27
Characterization of the Phosphoproteins and Protein Kinase Activity in mTOR Immunoprecipitates
Nishiuma, T., Hara, K., Tsujishita, Y., Kaneko, K., Shii, K., & Yonezawa, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9671 · Cited by 27
The mTOR pathway in Gliomas: From molecular insights to targeted therapies
Pournajaf, S., & Pourgholami, M. H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118237 · Cited by 27
Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018
Liu, W., Li, Q., Hu, J., Wang, H., Xu, F., & Bian, Q. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115150 · Cited by 26
mTOR in Lung Neoplasms
Krencz, I., Sebestyén, A. R., & Khoór, A. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-020-00796-1 · Cited by 26
METTL3 as a master regulator of translation in cancer: mechanisms and implications
Esteva-Socias, M., & Aguiló, F. (2024) · NAR Cancer · doi:10.1093/narcan/zcae009 · Cited by 25
mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle – Roles of Rap1 geranylgeranylation and mitochondrial dysfunction
Sanvee, G. M., Hitzfeld, L., Bouitbir, J., & Krähenbühl, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114750 · Cited by 25
Discovering new biology with drug-resistance alleles
Freedy, A. M., & Liau, B. B. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00865-9 · Cited by 25
TOR and paradigm change: cell growth is controlled
Hall, M. N. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-05-0311 · Cited by 25
Disruption of the vacuolar-type H+-ATPase complex in liver causes MTORC1-independent accumulation of autophagic vacuoles and lysosomes
Kissing, S., Rudnik, S., Daμμe, M., Lüllmann‐Rauch, R., Ichihara, A., Kornak, U., Eskelinen, E., Jabs, S., Heeren, J., Brabander, J. K. D., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1280216 · Cited by 25
Temsirolimus
Schulze, M., Stock, C., Zaccagnini, M., Teber, D., & Rassweiler, J. J. (2014) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-54490-3_24 · Cited by 25
The nephrotoxicity of new and old immunosuppressive drugs
Wm, B. (1998) · Renal Failure · doi:10.3109/08860229809045163 · Cited by 25
Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis
Hoshii, T., Matsuda, S., & Hirao, A. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu037 · Cited by 25
Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy
Eiden, A. M., Zhang, S., Gary, J. M., Simmons, J. K., & Mock, B. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3239 · Cited by 24
Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines
Dan, V. M., Muralikrishnan, B., Sanawar, R., Sahayasheela, V. J., Burkul, B. B., Srinivas, K. P., Lekshmi, A., Pradeep, N. S., Dastager, S. G., Santhakumari, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21249-5 · Cited by 24
Temsirolimus
Simpson, D., & Curran, M. P. (2008) · Drugs · doi:10.2165/00003495-200868050-00005 · Cited by 24
mTOR Signaling in Aquaculture Animals: A Central Nutrient‐Sensing Hub Orchestrating Growth, Metabolism, Health and Quality
Liu, Y., Mai, K., & Zhang, W. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70068 · Cited by 23
Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
Hou, G., Yang, S., Zhou, Y., Wang, C., Zhao, W. H., & Lu, Z. (2014) · Journal of Immunology Research · doi:10.1155/2014/845763 · Cited by 23
Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective
Brugaletta, S., Burzotta, F., & Sabaté, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902837998 · Cited by 23
Transcriptional Regulation of NK Cell Development by mTOR Complexes
Yang, C., & Malarkannan, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.566090 · Cited by 25
Protein Phosphorylation as a Key Mechanism of mTORC1/2 Signaling Pathways
Tchevkina, E. M., & Komelkov, A. V. (2012) · InTech eBooks · doi:10.5772/48274 · Cited by 26
Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC
Figlin, R. A. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1173 · Cited by 23
The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review
Hablase, R., Kyrou, I., Randeva, H. S., Karteris, E., & Chatterjee, J. (2024) · Cancers · doi:10.3390/cancers16112160 · Cited by 24
Rapamycin Induces Apoptosis When Autophagy is Inhibited in T-47D Mammary Cells and Both Processes are Regulated by Phlda1
Moad, A. I. H., Muhammad, T. S. T., Oon, C. E., & Tan, M. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9504-5 · Cited by 22
Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production
Gillespie, Z. E., MacKay, K., Sander, M., Trost, B., Dawicki, W., Wickramarathna, A. D., Gordon, J., Eramian, M., Kill, I. R., Bridger, J. M., et al. (2015) · Nucleus · doi:10.1080/19491034.2015.1128610 · Cited by 24
Fpr1, a primary target of rapamycin, functions as a transcription factor for ribosomal protein genes cooperatively with Hmo1 in Saccharomyces cerevisiae
Kasahara, K., Nakayama, R., Shiwa, Y., Kanesaki, Y., Ishige, T., Yoshikawa, H., & Kokubo, T. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008865 · Cited by 22
An Inhibitory Role of the G-Protein Regulator AGS3 in mTOR-Dependent Macroautophagy
Groves, B., Abrahamsen, H., Clingan, H., Frantz, M., Mavor, L. M., Bailey, J., & Ma, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008877 · Cited by 21
Quantitative and temporal measurement of dynamic autophagy rates
Beesabathuni, N. S., Park, S., & Shah, P. S. (2022) · Autophagy · doi:10.1080/15548627.2022.2117515 · Cited by 23
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
Xing, M., Wang, J., Yang, Q., Wang, Y., Li, J., Xiong, J., & Zhou, S. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03923-1 · Cited by 21
Molecular Networking and Whole-Genome Analysis Aid Discovery of an Angucycline That Inactivates mTORC1/C2 and Induces Programmed Cell Death
Dan, V. M., Sahayasheela, V. J., Sandesh, C. J., Sanawar, R., Lekshmi, A., Kumar, R., Kumar, T. R. S., Marelli, U. K., Dastager, S. G., & Pillai, M. R. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00026 · Cited by 21
FAP1, a homologue of human transcription factor NF‐X1, competes with rapamycin for binding to FKBP12 in yeast
Kunz, J., Loeschman, A., Deuter‐Reinhard, M., & Hall, M. N. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02105.x · Cited by 21
Advances in the regulatory mechanisms of mTOR in necroptosis
Xie, Y., Zhao, G., Lei, X., Cui, N., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1297408 · Cited by 21
On mTOR nomenclature
Hall, M. N. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130092 · Cited by 20
Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab
Patel, A. N., Mehnert, J. M., & Kim, S. (2012) · Clinical Medicine Insights Ear Nose and Throat · doi:10.4137/cment.s5129 · Cited by 20
mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss
Cortada, M., Levano, S., & Bodmer, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126368 · Cited by 21
Target of rapamycin controls hyphal growth and pathogenicity through FoTIP4 in Fusarium oxysporum
Li, L., Zhu, T., Song, Y., Luo, X., Datla, R. S. S., & Ren, M. (2021) · Molecular Plant Pathology · doi:10.1111/mpp.13108 · Cited by 21
Effects of aerobic exercise training on the protein kinase B (PKB)/mammalian target of rapamycin (mTOR) signaling pathway in aged skeletal muscle
Reynolds, T., Reid, P., Larkin, L. M., & Dengel, D. R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.12.005 · Cited by 20
BCR signal through α4 is involved in S6 kinase activation and required for B cell maturation including isotype switching and V region somatic hypermutation
Inui, S., Maeda, K., Hua, D. R., Yamashita, T., Yamamoto, H., Miyamoto, E., Aizawa, S., & Sakaguchi, N. (2002) · International Immunology · doi:10.1093/intimm/14.2.177 · Cited by 19
Cytokines in Type 2 Diabetes
Johnson, D. R., O’Connor, J. C., Satpathy, A. T., & Freund, G. G. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74017-1 · Cited by 19
Frogs as integrative models for understanding digestive organ development and evolution
Womble, M. A., Pickett, M. A., & Nascone‐Yoder, N. M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.02.001 · Cited by 19
Role of p70 S6 kinase in cytokine-regulated hemopoietic cell survival
Scheid, M. P., Charlton, L., Duronio, V., & Pelech, S. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-064 · Cited by 19
Metabolic regulation of Th17 and Treg cell balance by the mTOR signaling
Wang, Z., Xu, Z., Zong, M., & Fan, L. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100369 · Cited by 19
Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression
Reyes, A., Mohanty, A. R., Pharaon, R. R., & Massarelli, E. (2022) · Biomedicines · doi:10.3390/biomedicines11010099 · Cited by 18
Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress
Jiang, L., Chakraborty, P., Zhang, L., Wong, M., Hill, S. E., Webber, C. J., Libera, J., Blair, L. J., Wolozin, B. L., & Zweckstetter, M. (2023) · Science Advances · doi:10.1126/sciadv.add9789 · Cited by 19
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
Derwich-Rudowicz, A., Sykutera, M., Bromińska, B., Andrusiewicz, M., Ruchała, M., & Sawicka‐Gutaj, N. (2023) · Cancers · doi:10.3390/cancers15061665 · Cited by 18
TOR in plants: Multidimensional regulators of plant growth and signaling pathways
Rabeh, K., Oubohssaine, M., & Hnini, M. (2024) · Journal of Plant Physiology · doi:10.1016/j.jplph.2024.154186 · Cited by 20
Split Proteins and Reassembly Modules for Biological Applications
Bae, J., Kim, J., Choi, J., Lee, H., & Koh, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400123 · Cited by 19
Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells
Maldini, C. R., Messana, A., Bendet, P. B., Camblin, A. J., Musenge, F. M., White, M. L., Rocha, J. J., Coholan, L. J., Karaca, C., Li, F., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.06.022 · Cited by 18
Nutrient restriction causes reversible G2 arrest in Xenopus neural progenitors
McKeown, C. R., & Cline, H. T. (2019) · Development · doi:10.1242/dev.178871 · Cited by 19
The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction
Ucha, M., Roura‐Martínez, D., Ambrosio, E., & Higuera‐Matas, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944159 · Cited by 20
Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice
Dubois, M., Joncour, V. L., Tonon, M., Anouar, Y., Proust, F., Morin, F., Gandolfo, P., Joly, F., Hilber, P., & Castel, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113533 · Cited by 18
Query Chem: a Google-powered web search combining text and chemical structures
Klekota, J., Roth, F. P., & Schreiber, S. L. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl155 · Cited by 18
Development, synthesis and structure–activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei
Seufert, F., Kuhn, M., Hein, M., Weiwad, M., Vivoli, M., Norville, I. H., Sarkar‐Tyson, M., Marshall, L. E., Schweimer, K., Bruhn, H., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.025 · Cited by 18
PI3K-Related Kinases: Roles in Cell-Cycle Regulation and DNA Damage Responses
Tibbetts, R. S., & Abraham, R. T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-218-x:267 · Cited by 18
Self-citation
Advances with phospholipid signalling as a target for anticancer drug development.
Powis, G., Berggren, M. I., Gallegos, A. C., Frew, T., Hill, S., Kozikowski, A. P., Bonjouklian, R., Zalkow, L. H., Abraham, R. T., & Ashendel, C. L. (1995) · Acta Biochimica Polonica · doi:10.18388/abp.1995_4893 · Cited by 18
Self-citation
Molecular Biology of Malignant Mesothelioma: A Review
Pisick, E. P., & Salgia, R. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.09.012 · Cited by 18
mTOR
Wang, X., Wu, G., & Bazer, F. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00016-5 · Cited by 18
Ras/ MAPK dysregulation in development causes a skeletal myopathy in an activating BrafL597V mouse model for cardio‐facio‐cutaneous syndrome
Maeda, Y., Tidyman, W. E., Ander, B. P., Pritchard, C. A., & Rauen, K. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.309 · Cited by 17
Medical Aspects of mTOR Inhibition in Kidney Transplantation
Cuadrado‐Payán, E., Diekmann, F., & Cucchiari, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147707 · Cited by 17
Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model
Kramer, K., Yang, J., Swanson, W. B., Hayano, S., Toda, M., Pan, H., Kim, J. K., Krebsbach, P. H., & Mishina, Y. M. (2018) · genesis · doi:10.1002/dvg.23220 · Cited by 17
White spot syndrome virus directly activates mTORC1 signaling to facilitate its replication via polymeric immunoglobulin receptor-mediated infection in shrimp
Hong, P.-P., Li, C., Niu, G.-J., Zhao, X., & Wang, J. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010808 · Cited by 17
Therapeutic role of sirolimus in non-transplant kidney disease
Rangan, G. K., Nguyen, T., Mainra, R., Succar, L., Schwensen, K. G., Burgess, J. S., & Ho, K. O. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.014 · Cited by 17
Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70 S6K signalling pathway
Lin, T. A., & Lawrence, J. C. (1997) · Diabetologia · doi:10.1007/s001250051391 · Cited by 17
[Corrigendum] Rapamycin-induced autophagy activity promotes bone fracture healing in rats
Yang, G., Duan, X., Lin, D., Ten, L., Luo, D., Wang, L., & Lian, K. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9749 · Cited by 17
Introduction and overview
Shaw, L. M. J., Kaplan, B. E., & Brayman, K. L. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89018-9 · Cited by 17
mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses
Huynh, H., Levitz, R., Huang, R., & Kahn, J. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-03814-7 · Cited by 16
Experimental Approaches in Delineating mTOR Signaling
Qian, J., Su, S., & Liu, P. (2020) · Genes · doi:10.3390/genes11070738 · Cited by 17
Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace
Heimhalt, M., Berndt, A., Wagstaff, J. L., Anandapadamanaban, M., Perišić, O., Maslen, S., McLaughlin, S. H., Yu, C. W.-H., Masson, G. R., Boland, A., et al. (2021) · eLife · doi:10.7554/elife.68799 · Cited by 16
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Selective Inhibition of MAPKK Wis1 in the Stress-activated MAPK Cascade of Schizosaccharomyces pombe by Novel Berberine Derivatives
Jang, M. J., Jwa, M., Kim, J.-H., & Song, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111018200 · Cited by 16
Regulation of the Ca2+-activated chloride channel Anoctamin-1 (TMEM16A) by Ca2+-induced interaction with FKBP12 and calcineurin
Solano, A. S., Corral-Fernández, N. E., Segura-Covarrubias, G., Guzmán-Hernández, M. L., Aréchiga-Figueroa, I. A., Cruz‐Rangel, S., Pérez‐Cornejo, P., & Arreola, J. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102211 · Cited by 15
Rapamycin efficiently promotes cardiac differentiation of mouse embryonic stem cells
Lu, Q., Liu, Y., Wang, Y., Wang, W., Yang, Z., Li, T., Tian, Y., Chen, P., Ma, K., Jia, Z., et al. (2017) · Bioscience Reports · doi:10.1042/bsr20160552 · Cited by 15
Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells
Gopalakrishnan, K., Venkatesan, S., Low, E. S. H., & Hande, M. P. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.008 · Cited by 15
Precancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018009 · Cited by 14
Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in Drosophila cells
Xia, B., Viswanatha, R., Hu, Y., Mohr, S. E., & Perrimon, N. (2023) · eLife · doi:10.7554/elife.85542 · Cited by 14
Regulation of TORC2 Function and Localization in Yeast
Emmerstorfer‐Augustin, A., & Thorner, J. W. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011723-030346 · Cited by 15
Rapamycin Resistant Murine Th9 Cells Have a Stable In Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity
Mangus, C. W., Massey, P. R., Fowler, D. H., & Amarnath, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072305 · Cited by 14
Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells
Navarro‐Villarán, E., de la Cruz‐Ojeda, P., Contreras, L., González, R., Negrete, M., RodrÃguez-HernÃ¡ndez, M. A., MarÃn-GÃ³mez, L. M., Álamo-Martínez, J. M., Calvo, A., Gómez‐Bravo, M. Á., et al. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000230 · Cited by 14
Rapamycin recruits SIRT2 for FKBP12 deacetylation during mTOR activity modulation in innate immunity
Hu, L. T., Chen, F., Wu, C., Wang, J., Chen, S., Li, X., Wang, J., Wu, L., Ding, J., Wang, J.-C., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103177 · Cited by 14
Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors
Pal, S. K., & Figlin, R. A. (2010) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s1590 · Cited by 14
Halcyon days of TOR: Reflections on the multiple independent discovery of the yeast and mammalian TOR proteins
Livi, G. P. (2019) · Gene · doi:10.1016/j.gene.2018.12.046 · Cited by 14
Signaling Inhibitors in Metastatic Renal Cell Carcinoma
Escudier, B. J. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e3181867605 · Cited by 14
Brief communication: morphoproteomic analysis of osteolytic Langerhans cell histiocytosis with therapeutic implications.
Brown, R. E. (2005) · PubMed · Cited by 14
Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy?
Gentile, D., Esposito, M., & Grumati, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.930223 · Cited by 13
Perspectives on Agmatine Neurotransmission in Acute and Chronic Stressrelated Conditions
Hassanshahi, A., Soti, M., Ranjbar, H., Razavinasab, M., Pirmoradi, Z., Kohlmeier, K. A., Janahmadi, M., & Shabani, M. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230125104753 · Cited by 13

Authors: Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T.
Affiliations: Mayo Clinic (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Abraham, Robert T.
ORCID: Abraham, Robert T.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1995-01
Volume: 270
Issue: 2
Pages: 815-822
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.270.2.815
OpenAlex: W2158612356
Cited by: 887
References: 29
Citations by year: 2026: 10 · 2025: 20 · 2024: 28 · 2023: 37 · 2022: 38 · 2021: 37 · 2020: 39 · 2019: 31 · 2018: 25 · 2017: 38 · 2016: 25 · 2015: 31 · 2014: 26 · 2013: 31 · 2012: 29
FWCI: 9.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9442 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Mayo Foundation for Medical Education and Research
National Institutes of Health
National Institute of General Medical Sciences (R01GM047286, GM47286)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: rapamycin, FKBP12, mTOR, TOR1, TOR2, G1/S transition, T cells, immunosuppressants, rapamycin resistance, YAC-1 cells, cDNA cloning
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, DNA-Binding Proteins, Fungal Proteins, Heat-Shock Proteins, Humans, Molecular Sequence Data, Polyenes, Protein Kinases, Tumor Cells, Cultured, Lymphoma, T-Cell, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Phosphotransferases (Alcohol Group Acceptor), DNA Primers, DNA, Complementary, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Saccharomyces cerevisiae Proteins, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks